Fundz

Flush With Series A Funding, Daye Unwraps The Big Gynae Health Mission

PRIVATEOct 26, 2022

Round Type

Series A

BiotechnologyHealth Care

Description

Talking to Valentina Milanova, the still just 28-year-old founder of U.K. femtech Daye, is best described as an exhilarating experience. During our interview, she talks in and around her topic — building a startup supporting women’s sexual and reproductive health — non-stop for the best part of an hour, barely pausing for breath and without needing to be prompted to unpack the detail (although an engaged listener will be forced to interject with exclamations and follow-on questions as she lays out her sharp takes) — dispensing, at times, part-fascinating, part-horrifying insights from the coal-face of a field that’s suffered from a chronic lack of research and innovation for far too long.

Quick answer

Daye raised an undisclosed amount in a Series A round, dated October 26, 2022.

How much did Daye raise?
Daye raised an undisclosed amount in a Series A round on October 26, 2022.
What does Daye do?
Daye exists to bridge the gender gap in medical research and innovation

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Daye that raised within 45 days of this round, from Fundz verified event records.

  • Sonde Health raised $19M (Series B) on December 8, 2022.
  • Ubie raised an undisclosed amount (Series C) on December 8, 2022.
  • Perceiv AI raised an undisclosed amount on December 8, 2022.
  • Eigen raised an undisclosed amount (Funding Round) on December 8, 2022.
  • ExPLoRNA Therapeutics raised an undisclosed amount (Funding Round) on December 7, 2022.
  • VOCxi Health raised $3.9M (Seed) on December 7, 2022.

Who to call at Daye, and when

A new round usually means Daye is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Daye raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Daye, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Daye. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Daye

About

Daye exists to bridge the gender gap in medical research and innovation

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Daye raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Daye's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Daye raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.